
Sun Pharmaceutical Industries Q1 Results Live : Sun Pharmaceutical Industries declared their Q1 results on 01 Aug, 2024. The topline increased by 5.96% & the profit increased by 40.2% YoY.
As compared to the previous quarter the revenue grew by 5.59% and the profit increased by 6.82%.
The Selling, general & administrative expenses rose by 6.75% q-o-q & increased by 2.19% Y-o-Y.
The operating income was up by 28.36% q-o-q & increased by 27.48% Y-o-Y.
The EPS is ₹11.8 for Q1 which increased by 24.37% Y-o-Y.
Sun Pharmaceutical Industries has delivered 2.97% return in the last 1 week, 21.82% return in last 6 months and 36.19% YTD return.
Currently the Sun Pharmaceutical Industries has a market cap of ₹412529.7 Cr and 52wk high/low of ₹1746.45 & ₹1068.35 respectively.
As of 02 Aug, 2024 out of 30 analysts covering the company, 2 analysts have given Sell rating, 7 analysts have given Hold rating, 12 analysts have given Buy rating & 9 analysts have given Strong Buy rating.
The consensus recommendation as on 02 Aug, 2024 was to Buy.
Sun Pharmaceutical Industries Financials
| Period | Q1 | Q4 | Q-o-Q Growth | Q1 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 12652.75 | 11982.9 | +5.59% | 11940.84 | +5.96% |
| Selling/ General/ Admin Expenses Total | 2454.62 | 2299.34 | +6.75% | 2402.04 | +2.19% |
| Depreciation/ Amortization | 655.13 | 650.36 | +0.73% | 651.32 | +0.58% |
| Total Operating Expense | 9649.81 | 9643.37 | +0.07% | 9585.3 | +0.67% |
| Operating Income | 3002.94 | 2339.53 | +28.36% | 2355.54 | +27.48% |
| Net Income Before Taxes | 3423.5 | 2815.52 | +21.59% | 2481.14 | +37.98% |
| Net Income | 2835.62 | 2654.58 | +6.82% | 2022.54 | +40.2% |
| Diluted Normalized EPS | 11.8 | 11.5 | +2.59% | 9.49 | +24.37% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.